Schisto.org Home Image: The Schistosomiasis Control Initiative Logo
Schisto.org Home    


About the SCI
Objectives
Funding
Partners
Working Practices
Project Management
Staff Profiles

Partners

The SCI's major funding partner is the Bill and Melinda Gates Foundation, and the major operational partners are the Department of Infectious Disease Epidemiology, Imperial College London; the Harvard Center for Population & Development Studies, Boston; and the World Health Organisation, both in Geneva and the African Regional Office. The SCI will be a new and important partnership contributing to the World Health Organisation’s work in schistosomiasis research and control activities.

The SCI also works closely with a number of other organisations: 

  • The World Food Programme - by assisting the WFP to deliver deworming pills together with the food they provide through the School Feeding programme.
  • International Dispensary Association (IDA), Holland, to provide high quality reasonably priced drugs to certain countries.
  • The Danish Bilharzia Laboratory (DBL) Denmark, which has an excellent track record of research and training in Africa. In particular DBL will assist SCI to reach the goal of treating millions of people in Uganda by training health personnel in 20 or more districts. SCI expects that DBL will participate in other selected countries during the expansion phase.
  • The Carter Center, Atlanta, is currently assisting Nigerian health authorities in annual mass drug administration (MDA) and health education efforts in 9 states. The activities include distributing ivermectin for onchocerciasis in all 9 states, distributing praziquantel to treat urinary schistosomiasis in three states, and distributing ivermectin and albendazole combination therapy for lymphatic filariasis in two states. Neither The Carter Center nor Nigeria receives SCI support. However, SCI expects that the experience gained in Nigeria by The Carter Center can be put to great use for future schistosomiasis control integrated with other MDA efforts.
  • The Center for Disease Control, Atlanta, (CDC) which will assist SCI by providing an independent monitoring service for measuring the SCI achievements.
  • The Partnership for Child Development (PCD), based in the same Department at Imperial College London (DIDE), PCD and SCI have overlapping mission statements, and will collaborate and share resources in several countries.
  • African public and private organizations, and government ministries in several possible implementing countries such as Burkina Faso, Cameroon, Ghana, Kenya, Níger, Nigeria, Malawi, Mali, Sudan, Tanzania, Uganda, Zambia.
  • NIH, The Wellcome TrustDFID, and The United States Agency for International Development (USAID) are all donors which may contribute directly or indirectly to the initiative against schistosomiasis by supporting research or control operations.
  • The World Bank which through its FRESH initiative (Focussing Resources Effectively for School Health) and loans to developing countries is pushing forward the school health programmes in many countries.
  • The London School of Hygiene and Tropical Medicine with the Department of Infectious and Tropical Diseases. In particular Dr. Simon Brooker will assist SCI in the development of surveillance maps, and use of GIS technology as required in the SCI participating countries.
  • The Earth Institute, Rwanda branch, which is the main implementer of the NTD Control Programme in Rwanda.
  • CBM, Burundi branch, which is the main partner of the Ministry of Public Health for the implementation of the NTD Control Programme in Burundi.

     
    About | News | Schistosomiasis | Programmes | Research | Reports | Contact | Sitemap

© Schistosomiasis Control Initiative 2008

Department of Infectious Disease Epidemiology
Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG

email:
schisto@imperial.ac.uk